These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Use of 3-hour daily hemodialysis and paricalcitol in patients with severe secondary hyperparathyroidism: A case series. Achinger SG; Mizani MR; Ayus JC Hemodial Int; 2010 Apr; 14(2):193-9. PubMed ID: 20337743 [TBL] [Abstract][Full Text] [Related]
28. A randomized, parallel, open-label study to compare once-daily sevelamer carbonate powder dosing with thrice-daily sevelamer hydrochloride tablet dosing in CKD patients on hemodialysis. Fishbane S; Delmez J; Suki WN; Hariachar SK; Heaton J; Chasan-Taber S; Plone MA; Moe S Am J Kidney Dis; 2010 Feb; 55(2):307-15. PubMed ID: 20042256 [TBL] [Abstract][Full Text] [Related]
29. Sodium thiosulfate, bisphosphonates, and cinacalcet for calciphylaxis. Raymond CB; Wazny LD; Sood AR CANNT J; 2009; 19(4):25-7; quiz 28-9. PubMed ID: 20136032 [No Abstract] [Full Text] [Related]
30. Multi-modal treatment of calciphylaxis with sodium-thiosulfate, cinacalcet and sevelamer including long-term data. Salmhofer H; Franzen M; Hitzl W; Koller J; Kreymann B; Fend F; Hauser-Kronberger C; Heemann U; Berr F; Schmaderer C Kidney Blood Press Res; 2013; 37(4-5):346-59. PubMed ID: 24247072 [TBL] [Abstract][Full Text] [Related]
31. The renal dietitian's role in managing hyperphosphatemia and secondary hyperparathyroidism in dialysis patients: a national survey. Martin CJ; Reams SM J Ren Nutr; 2003 Apr; 13(2):133-6. PubMed ID: 12671837 [TBL] [Abstract][Full Text] [Related]
32. Effect of sevelamer hydrochloride on bone in experimental uremic rats. Kuwahara M; Inoshita S; Terada Y; Sasaki S Ther Apher Dial; 2009 Feb; 13(1):42-8. PubMed ID: 19379169 [TBL] [Abstract][Full Text] [Related]
33. The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial. Parfrey PS; Chertow GM; Block GA; Correa-Rotter R; Drüeke TB; Floege J; Herzog CA; London GM; Mahaffey KW; Moe SM; Wheeler DC; Dehmel B; Trotman ML; Modafferi DM; Goodman WG J Clin Endocrinol Metab; 2013 Dec; 98(12):4834-44. PubMed ID: 24108314 [TBL] [Abstract][Full Text] [Related]
34. [Chronic kidney disease (CKD) and bone. Control of CKD-MBD from the viewpoint of the medical cost]. Hamano T Clin Calcium; 2009 Apr; 19(4):529-36. PubMed ID: 19329832 [TBL] [Abstract][Full Text] [Related]
35. Effects of calcium carbonate, sevelamer hydrochloride or pantoprazole on the pharmacokinetics of cinacalcet. Padhi D; Harris R; Sullivan JT Clin Drug Investig; 2014 Aug; 34(8):537-44. PubMed ID: 24935051 [TBL] [Abstract][Full Text] [Related]
36. Does Sevelamer reduce mortality by slowing of progression of coronary calcification? Badve SV; Magner PO Kidney Int; 2007 Jun; 71(12):1328-9. PubMed ID: 17554361 [No Abstract] [Full Text] [Related]